Effect of polyclonal activators on cytokine production by blood cells and by malignant breast cancer cells


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The production of cytokines by peripheral blood cells and biopsy specimens of tumors stimulated by polyclonal activators (PAs) was evaluated in 34 patients with invasive ductal breast carcinoma using enzyme-linked immunosorbent assay (ELISA). Positive correlation between the stimulation index of polyclonal activators (SIPA) for IL-18 production by the tumor and the relative content of poorly differentiated cells was revealed. The latter, in turn, was positively correlated with the numbers of normal and pathologic mitoses and the degree of malignancy. Cancer cells can produce IL-18, which is involved in the process of angiogenesis, stimulates invasion and metastasis. Decrease in SIPA for the production of IL-6 and GCSF by peripheral blood cells could serve as an indicator of malignant progression in invasive ductal breast carcinoma.

About the authors

T. A. Kunts

Research Center for Molecular Biology and Biophysics, Siberian Branch

Author for correspondence.
Email: tkunts@ngs.ru
Russian Federation, Novosibirsk

K. V. Karpukhina

Novosibirsk State Medical University

Email: tkunts@ngs.ru
Russian Federation, Novosibirsk

E. S. Mikhaylova

Novosibirsk State Medical University

Email: tkunts@ngs.ru
Russian Federation, Novosibirsk

I. O. Marinkin

Research Center for Molecular Biology and Biophysics, Siberian Branch

Email: tkunts@ngs.ru
Russian Federation, Novosibirsk

N. A. Varaksin

ZAO Vector-Best

Email: tkunts@ngs.ru
Russian Federation, Kol’tsovo, Novosibirsk oblast

A. I. Autenshlyus

Novosibirsk State Medical University

Email: tkunts@ngs.ru
Russian Federation, Novosibirsk

V. V. Lyakhovich

Novosibirsk State Medical University

Email: tkunts@ngs.ru
Russian Federation, Novosibirsk

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2016 Pleiades Publishing, Ltd.